Healio (6/29, Gramigna) reports, “Antipsychotic-naive patients with first-episode psychosis exhibited widespread functional dysconnectivity at baseline,” researchers concluded in a “secondary analysis of a randomized clinical trial” that included data on “59 antipsychotic-naive patients with first-episode psychosis receiving either a second-generation antipsychotic or a placebo…over six months of treatment,” as well as 27 healthy individuals who served as controls. Study participants underwent resting state functional magnetic resonance imaging at “baseline, three months and 12 months…with data analysis between May 2019 and August 2020.” The findings were published online June 23 in JAMA Psychiatry.
Related Links:
— “Functional dysconnectivity ‘widespread’ in antipsychotic-naive first-episode psychosis “Joe Gramigna, Healio, June 29, 2021